Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals, 22178 [2020-08352]
Download as PDF
<![CDATA[
22178
Federal Register / Vol. 85, No. 77 / Tuesday, April 21, 2020 / Notices
In light of
the ongoing Coronavirus (COVID–19)
outbreak, the Commission has
determined to extend postponement of
all section 337 in-person hearings until
June 10, 2020. Commission
Administrative Law Judges (‘‘ALJ’’) are
directed to notify all affected parties and
to schedule new dates for the hearings
as appropriate. ALJs may otherwise
conduct their investigations in
accordance with their established
procedures.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
SUPPLEMENTARY INFORMATION:
By order of the Commission.
Issued: April 15, 2020.
Lisa Barton,
Secretary to the Commission.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 3, 2018,
Cedarburg Pharmaceuticals, 870 Badger
Circle, Grafton, Wisconsin 53024–0000
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substances:
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Tetrahydrocannabinols ..
Methylphenidate ............
Nabilone ........................
4-Anilino-N-phenethyl-4piperidine (ANPP).
Fentanyl .........................
Schedule
7370
1724
7379
8333
I
II
II
II
9801
II
[FR Doc. 2020–08388 Filed 4–20–20; 8:45 am]
The company plans to manufacture
bulk active pharmaceutical ingredients
(API) for distribution to its customers. In
reference to drug code 7370
(Tetrahydrocannabinols) the company
plans to bulk manufacture as synthetic.
No other activity for this drug code is
authorized for this registration.
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–596]
Bulk Manufacturer of Controlled
Substances Application: Cedarburg
Pharmaceuticals
ACTION:
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–08352 Filed 4–20–20; 8:45 am]
Notice of application.
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 22, 2020.
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–606]
Importer of Controlled Substances
Application: Sigma Aldrich Co., LLC
ACTION:
Notice of application.
Registered bulk manufacturer of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 21, 2020. Such persons
may also file a written request for a
hearing on the application on or before
May 21, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on January 27, 2020,
Sigma Aldrich Co., LLC, 3500 DeKalb
Street, Saint Louis, Missouri 63118
applied to be registered as an importer
of the following basic class(es) of
controlled substances:
DATES:
lotter on DSKBCFDHB2PROD with NOTICES
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
VerDate Sep<11>2014
21:19 Apr 20, 2020
Jkt 250001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
E:\FR\FM\21APN1.SGM
21APN1
1235
1237
1248
2010
7370
7391
7392
7396
7400
7404
7405
7411
7435
7493
9200
9313
2125
2315
7379
7471
9180
9190
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 85, Number 77 (Tuesday, April 21, 2020)]
[Notices]
[Page 22178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08352]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-596]
Bulk Manufacturer of Controlled Substances Application: Cedarburg
Pharmaceuticals
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 22, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 3, 2018, Cedarburg Pharmaceuticals, 870
Badger Circle, Grafton, Wisconsin 53024-0000 applied to be registered
as a bulk manufacturer of the following basic class(es) of controlled
substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols.................. 7370 I
Methylphenidate........................ 1724 II
Nabilone............................... 7379 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture bulk active pharmaceutical
ingredients (API) for distribution to its customers. In reference to
drug code 7370 (Tetrahydrocannabinols) the company plans to bulk
manufacture as synthetic. No other activity for this drug code is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08352 Filed 4-20-20; 8:45 am]
BILLING CODE 4410-09-P
